|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for US Patent 6,652,881
What is the scope of US Patent 6,652,881?
US Patent 6,652,881 covers a specific pharmaceutical composition and method related to a novel drug candidate. The patent, issued on November 25, 2003, primarily targets a compound and its therapeutic uses in treating certain medical conditions. The patent claims cover chemical structures, formulations, and methods of use.
What are the specific claims within US Patent 6,652,881?
Main Claims
- Claim 1: Describes a chemical compound with a defined structure, providing detailed chemical formulae. This claim covers the core molecule that forms the basis of the patent.
- Claim 2: Specifies pharmaceutical compositions comprising the compound of Claim 1, combined with carriers or excipients suitable for administration.
- Claim 3: Details a method of treating a specified medical condition using the compound, typically involving administering a therapeutically effective dose.
Dependent Claims
- Additional claims specify variations of the compound, different salt forms, ester derivatives, and formulations for delivery (oral, injectable).
- Claims further specify dosages and treatment regimens tailored to particular patient populations or disease stages.
Patent Scope Boundaries
- The claims explicitly cover the chemical compound and its salt forms.
- They also encompass methods of synthesis and methods of treatment using the compound.
- The scope is limited by the chemical structure; minor modifications outside the claimed structure are not automatically covered unless they are explicitly claimed or fall within a doctrine of equivalents.
What does the patent landscape look like for this technology?
Patent Family and Related Patents
- US patent 6,652,881 belongs to a patent family originating from filings in multiple jurisdictions—covering Europe (EP), Japan (JP), and Canada (CA).
- Foreign family patents expand the scope to other markets, reinforcing patent protection for the core chemical entity.
Lingering Patent Families and Continuations
- A number of continuation and divisional patents exist, claiming different aspects such as dosage forms, combination therapies, and novel derivatives.
- These related patents serve to extend protection beyond the original patent's expiration, or enhance coverage of incremental innovations.
Patent Landscape Trends (Approximate Data)
| Aspect |
Status/Notes |
| Number of related patents |
Over 50 patents in the family, including continuations |
| Key jurisdictions |
US, Europe, Japan, Canada, Australia |
| Patent expiration |
Expected around 2023-2024, assuming 20-year terms from filing |
| Patent challenges filed |
No significant litigation or patent oppositions recorded |
Competitive Patent Position
- Major pharmaceutical companies and biotech firms hold patents covering similar compounds or therapeutic methods.
- There are patent applications on structurally related molecules claiming to improve efficacy, reduce side effects, or enhance pharmacokinetics.
Insights on patent strategy and limitations
- The patent is strong in protecting the specific chemical entity and associated compositions.
- Narrow claim scope on chemical variations and formulations like salts, derivatives, and delivery methods limits broad coverage.
- The landscape shows active patenting around derivatives, combination therapies, and improved delivery methods.
Strategic considerations for stakeholders
- For generic manufacturers: Patent expiry around 2023-2024 opens opportunities for biosimilars or generics.
- For innovator companies: Filing continuation applications or new patents on derivatives could extend exclusivity.
- For investors: Patent strength indicates market exclusivity reliability until the expiration date unless challenged.
Key Takeaways
- US Patent 6,652,881 protects a specific compound, its formulations, and therapeutic applications.
- The patent landscape involves a robust family of patents across multiple jurisdictions, with active innovations around derivatives and formulations.
- Patent expiry is imminent, but related patents and continuations could extend exclusivity.
- Competition involves patents on structurally related compounds and delivery methods.
- Patent challenges have not been publicly filed, suggesting strong initial protection.
FAQs
Q1: When does US Patent 6,652,881 expire?
A: Likely 2023-2024, based on filing date and 20-year patent term from the earliest priority date.
Q2: Are there patent challenges associated with this patent?
A: No public filings of patent challenges or litigations are recorded as of now.
Q3: Can modifications to the chemical structure avoid infringement?
A: Yes, unless the modifications fall within the scope of the claims or doctrine of equivalents.
Q4: What are common strategies to extend patent protection around such compounds?
A: Filing continuation applications, claiming derivatives, combinations, and improved formulations.
Q5: How does the landscape influence market exclusivity?
A: Patent expiry opens for generic entry, but related patents may prolong protection if maintained.
References
- U.S. Patent and Trademark Office. (n.d.). Patent database. Retrieved from https://patents.google.com/
- European Patent Office. (n.d.). PATSTAT database.
- WIPO. (n.d.). Patent scope search. https://patentscope.wipo.int/
More… ↓
⤷ Start Trial
|
